Orthogonal tRNA Cell Engineering for Higher Non-Natural Protein Yield

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

The low yield of non-natural amino acid-containing protein production in mammalian cells is hindered by induced apoptosis and cell stressors, particularly during bioreactor scale-up processes.

Innovation Solution

Incorporation of orthogonal aminoacyl tRNA synthetase (O-RS) and orthogonal suppressor tRNA (O-tRNA) into eukaryotic cells, combined with targeted inactivation of specific sites or regions, such as Bcl-2, to reduce apoptosis and enhance protein production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If orthogonal aminoacyl tRNA synthetase and orthogonal suppressor tRNA are introduced into mammalian cells to enable non-natural amino acid incorporation, then the capability to produce non-natural amino acid-containing proteins is achieved, but the production yield remains low due to induced apoptosis

Engineering Contradiction:

Improvecapability to incorporate non-natural amino acidVSAvoidproduction yield

Core Design Contradiction:

Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent converts the harmful effect of uncharged tRNA accumulation (which causes apoptosis) into a beneficial selection mechanism. By introducing a suicide gene that is suppressed by the orthogonal tRNA system, cells that successfully incorporate non-natural amino acids are selected and survive, while cells with dysfunctional orthogonal systems die. This transforms the apoptotic response from a detrimental side effect into a useful tool for enriching high-producing cell populations.

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent modifies cellular parameters by introducing the orthogonal tRNA synthetase system and adjusting culture conditions to optimize non-natural amino acid incorporation. By changing the genetic composition of the cells and optimizing expression parameters, the system achieves both the capability to incorporate non-natural amino acids and improved production yields.

Inventive Principle:

Principle #35Parameter changes

2Productivity

If cell culture is scaled up in bioreactor processes to increase production capacity, then the potential output is improved, but cell stressors activate intrinsic apoptotic pathways and reduce yield

Engineering Contradiction:

Improvepotential outputVSAvoidcell viability

Core Design Contradiction:

ProductivityVSReliability

Solution Approach 1:

The patent applies preliminary selection pressure during cell line development by using the suicide gene system to pre-enrich populations of cells with functional orthogonal tRNA systems before scale-up. This preliminary action ensures that only cells capable of proper non-natural amino acid incorporation and stress resistance are carried forward into bioreactor production, preventing apoptosis issues during scaling.

Inventive Principle:

Principle #10Preliminary action

3Productivity

If excessive uncharged tRNA accumulates in the system to drive non-natural amino acid incorporation, then the incorporation efficiency is improved, but induced apoptosis increases and reduces overall protein production

Engineering Contradiction:

Improveincorporation efficiencyVSAvoidapoptosis induction

Core Design Contradiction:

ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent converts the harmful accumulation of uncharged tRNA into a beneficial selection mechanism. The suicide gene system is designed to be suppressed by the orthogonal tRNA, so cells that successfully maintain the orthogonal system and incorporate non-natural amino acids survive, while cells with tRNA imbalance or system failure die. This transforms the potentially harmful tRNA accumulation into a useful selection pressure.

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Significantly increases the yield of non-natural amino acid-containing proteins by up to 10-fold through reduced apoptosis and improved cell viability, as demonstrated in CRISPR-mediated knockout experiments.

Implementation Method 1

Incorporation of orthogonal aminoacyl tRNA synthetase (O-RS) and orthogonal suppressor tRNA (O-tRNA) into eukaryotic cells, combined with targeted inactivation of specific sites or regions

Methodology Applied

Scientific EffectTranslation:

Implementation Method 2

as demonstrated in CRISPR-mediated knockout experiments

Methodology Applied

Scientific EffectCRISPR-mediated gene knockout:

Data Source

PatentUS12577575B2Methods and compositions for promoting non-natural amino acid-containing protein production

Publication Date: 2026.03.17 AMBRX INC

AI summary

Disclosed herein are methods and compositions for generation of cell lines to promote unnatural amino acid-containing protein production using genome engineering technology.